Clinical Trial

Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature

Name: Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature — clinical trial record (NCT04798690)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2021-03-12; most recent amendment 2026-07-19.

Trial Details

NCT Number	NCT04798690
Lead Sponsor	Dong-A ST Co., Ltd.
Conditions	Growth Hormone Deficiency, Idiopathic Short Stature, Turner Syndrome, Small for Gestational Age
Enrollment	5,000 participants
Start Date	2021-02-08
Primary Completion	2035-02 (estimated)
Study Completion	2035-02 (estimated)
Updated on ClinicalTrials.gov	2026-07-21